Newsmeme!
Discover News you didn't know existed
Pathogen
News
Symphogen And Meiji Seika Kaisha Ltd. Achieve Milestone In Discovery Collaboration For Recombinant Polyclonal ...
Published December 4, 2008, 11:15 am, Medical News Today
Symphogen A/S and Meiji Seika Kaisha Ltd. (TSE: 2202) announced today the advancement of their collaboration for the discovery, development and commercialization of a recombinant polyclonal antibody therapeutic, Sym006, that targets an undisclosed bacterial pathogen. The companies, who initiated the collaboration in December 2006, are moving the program into preclinical development.
Tags
No tags found at this time. Be the first to tag this news item, learn more.
Imagery
Related Pathogen Stories
From Various News Sources
Symphogen and Meiji Seika Kaisha Ltd. Achieve Milestone in Discovery ... - Phramalive.com
COPENHAGEN, Denmark & TOKYO--(BUSINESS WIRE)--Dec 4, 2008 - Symphogen A/S and Meiji Seika Kaisha Ltd. (TSE: 2202) announced today the advancement of their collaboration for the discovery, development and commercialization of a recombinant polyclonal ...
Related Social Bookmarks
None found at this time.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |